← Back to Search

Device

Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device

N/A
Waitlist Available
Led By Silvia Delgado Villalta, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up o2 saturation measured immediately prior to treatment and 2 hours after treatment - one-time pre/post treatment in week 1; and one-time pre/post treatment in week 2
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two airway clearance devices used to treat cystic fibrosis. It aims to find if one is better than the other, and if not, provides an alternative device which is cheaper and portable.

Eligible Conditions
  • Cystic Fibrosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~o2 saturation measured immediately prior to treatment and 2 hours after treatment - one-time pre/post treatment in week 1; and one-time pre/post treatment in week 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and o2 saturation measured immediately prior to treatment and 2 hours after treatment - one-time pre/post treatment in week 1; and one-time pre/post treatment in week 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Oxygen Saturation % by Pulse Oximetry

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PIAPD-Portable Internal Airway Percussion deviceExperimental Treatment1 Intervention
There will be an outpatient arm using the PIAPD-Portable Internal Airway Percussion Device.
Group II: SACD-Standard Airway Clearance deviceActive Control1 Intervention
There will be an Outpatient Arm using the SACD, VEST (High Frequency Chest Wall Oscillation VEST) Standard Airway Clearance Device.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,222 Total Patients Enrolled
8 Trials studying Cystic Fibrosis
426 Patients Enrolled for Cystic Fibrosis
Silvia Delgado Villalta, MDPrincipal InvestigatorUniversity of Florida
~0 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top